MiR-186 and 326 predict the prognosis of pancreatic ductal adenocarcinoma and affect the proliferation and migration of cancer cells

PLoS ONE

Volumn 10, Issue 3, 2015, Pages

  Zhang, Zheng Liang ^a   Bai, Zheng Hai ^a   Wang, Xiao Bo ^a   Bai, Ling ^a   Miao, Fei ^a   Pei, Hong Hong ^a  

^a THE SECOND AFFILIATED HOSPITAL OF XI AN JIAOTONG UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

MICRORNA; MICRORNA 186; MICRORNA 326; UNCLASSIFIED DRUG; MIRN186 MICRORNA, HUMAN; MIRN326 MICRORNA, HUMAN;

3' UNTRANSLATED REGION; ADULT; AGED; ARTICLE; CANCER GROWTH; CANCER PROGNOSIS; CLINICAL FEATURE; CONTROLLED STUDY; FEMALE; GENE; HUMAN; HUMAN CELL; HUMAN TISSUE; LONG TERM SURVIVAL; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; NR5A2 GENE; OVERALL SURVIVAL; PANCREAS ADENOCARCINOMA; PREDICTION; PREDICTIVE VALUE; RNA BINDING; SHORT TERM SURVIVAL; SURVIVAL TIME; TUMOR INVASION; VALIDATION STUDY; CELL MOTION; CELL PROLIFERATION; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; MIDDLE AGED; MORTALITY; PANCREAS CARCINOMA; PANCREAS TUMOR; PATHOLOGY; PROGNOSIS; SURVIVAL RATE; TUMOR CELL LINE;

AGED; CARCINOMA, PANCREATIC DUCTAL; CELL LINE, TUMOR; CELL MOVEMENT; CELL PROLIFERATION; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MALE; MICRORNAS; MIDDLE AGED; PANCREATIC NEOPLASMS; PROGNOSIS; SURVIVAL RATE;

EID: 84929340738     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0118814     Document Type: Article

References (37)

1. Saif MW (2006) Pancreatic cancer: highlights from the 42nd annual meeting of the American Society of Clinical Oncology, 2006. JOP 7:337-348. PMID: 16832131
2. Long J, Luo GP, Xiao ZW, Liu ZQ, Guo M, Liu L, et al. (2014) Cancer statistics: current diagnosis and treatment of pancreatic cancer in Shanghai, China. Cancer Lett 346:273-277. doi: 10.1016/j.canlet. 2014.01.004 PMID: 24462819
3. Yadav D, Lowenfels AB (2013) The epidemiology of pancreatitis and pancreatic cancer. Gastroenterology 144:1252-1261. doi: 10.1053/j.gastro.2013.01.068 PMID: 23622135
4. Hezel AF, Kimmelman AC, Stanger BZ, Bardeesy N, Depinho RA (2006) Genetics and biology of pancreatic ductal adenocarcinoma. Genes Dev 20:1218-1249. PMID: 16702400
5. Bhat K, Wang F, Ma Q, Li Q, Mallik S, Hsieh TC, et al. (2012) Advances in biomarker research for pancreatic cancer. CurrPharm Des 18:2439-2451. PMID: 22372502
6. Nagao Y, Hisaoka M, Matsuyama A, Kanemitsu S, Hamada T, Fukuyama T, et al. (2012) Association of microRNA-21 expression with its targets, PDCD4 and TIMP3, in pancreatic ductal adenocarcinoma. Mod Pathol 25:112-121. doi: 10.1038/modpathol.2011.142 PMID: 21983937
7. Kent OA, Mendell JT (2006) A small piece in the cancer puzzle: microRNAs as tumor suppressors and oncogenes. Oncogene 25:6188-6196. PMID: 17028598
8. Ahmad J, Hasnain SE, Siddiqui MA, Ahamed M, Musarrat J, Al-Khedhairy AA (2013) MicroRNA in carcinogenesis & cancer diagnostics: a new paradigm. Indian J Med Res 137:680-694. PMID: 23703335
9. Laurila EM, Sandstrom S, Rantanen LM, Autio R, Kallioniemi A (2012) Both inhibition and enhanced expression of miR-31 lead to reduced migration and invasion of pancreatic cancer cells. Genes Chromosomes Cancer 51:557-568. doi: 10.1002/gcc.21941 PMID: 22344632
10. Jiao LR, Frampton AE, Jacob J, Pellegrino L, Krell J, Giamas G, et al. (2012) MicroRNAs targeting oncogenes are down-regulated in pancreatic malignant transformation from benign tumors. PLoS One 7:e32068. doi: 10.1371/journal.pone.0032068 PMID: 22384141
11. Hamada S, Satoh K, Fujibuchi W, Hirota M, Kanno A, Unno J, et al. (2012) MiR-126actsasatumor suppressor in pancreatic cancer cells via the regulation of ADAM9. Mol Cancer Res 10:3-10. doi: 10. 1158/1541-7786. MCR-11-0272 PMID: 22064652
12. Liffers ST, Munding JB, Vogt M, Kuhlmann JD, Verdoodt B, Nambiar S, et al. (2011) MicroRNA-148ais down-regulated in human pancreatic ductal adenocarcinomas and regulates cell survival by targeting CDC25B. Lab Invest 91:1472-1479. doi: 10.1038/labinvest.2011.99 PMID: 21709669
13. Zhang Y, Li M, Wang H, Fisher WE, Lin PH, Yao Q, et al. (2009) Profiling of 95 microRNAs in pancreatic cancer cell lines and surgical specimens by real-time PCR analysis. World J Surg 33:698-709. doi: 10.1007/s00268-008-9833-0 PMID: 19030927
14. Yu J, Ohuchida K, Mizumoto K, Fujita H, Nakata K, Tanaka M (2010) MicroRNA miR-17-5p is overexpressed in pancreatic cancer, associated with a poor prognosis, and involved in cancer cell proliferation and invasion. Cancer Biol Ther 10:748-757. doi: 10.4161/cbt.10.8.13083 PMID: 20703102
15. Xue Y, Abou Tayoun AN, Abo KM, Pipas JM, Gordon SR, Gardner TB, et al. (2013) MicroRNAs as diagnostic markers for pancreatic ductal adenocarcinoma and its precursor, pancreatic intraepithelial neoplasm. Cancer Genet 206:217-221. doi: 10.1016/j.cancergen. 2013.05.020 PMID: 23933230
16. Papaconstantinou IG, Manta A, Gazouli M, Lyberopoulou A, Lykoudis PM, Polymeneas G, et al. (2013) Expression of microRNAs in patients with pancreatic cancer and its prognostic significance. Pancreas 42:67-71. doi: 10.1097/MPA.0b013e3182592ba7 PMID: 22850622
17. Bloomston M, Frankel WL, Petrocca F, Volinia S, Alder H, Hagan JP, et al. (2007) MicroRNA expression patterns to differentiate pancreatic adenocarcinoma from normal pancreas and chronic pancreatitis. JAMA 297:1901-1908. PMID: 17473300
18. Dayem Ullah AZ, Cutts RJ, Ghetia M, Gadaleta E, Hahn SA, Crnogorac-Jurcevic T, et al. (2014) The pancreatic expression database: recent extensions and updates. Nucleic Acids Res 42:D944-949. doi: 10.1093/nar/gkt959 PMID: 24163255
19. Giovannetti E, Van Der Velde A, Funel N, Vasile E, Perrone V, Leon LG, et al. (2012) High-throughput microRNA (miRNAs) arrays unravel the prognostic role of MiR-211 in pancreatic cancer. PLoSOne 7:e49145. doi: 10.1371/journal.pone.0049145 PMID: 23155457
20. Jamieson NB, Morran DC, Morton JP, Ali A, Dickson EJ, Carter CR, et al. (2012) MicroRNA molecular profiles associated with diagnosis, clinicopathologic criteria, and overall survival in patients with resectable pancreatic ductal adenocarcinoma. Clin Cancer Res 18:534-545. doi: 10.1158/1078-0432. CCR-11-0679 PMID: 22114136
21. Lewis BP, Shih IH, Jones-Rhoades MW, Bartel DP, Burge CB (2003) Prediction of mammalian micro-RNA targets. Cell 115:787-798. PMID: 14697198
22. John B, Enright AJ, Aravin A, Tuschl T, Sander C, Marks DS (2004) Human MicroRNA targets. PLoS Biol 2:e363. PMID: 15502875
23. Kertesz M, Iovino N, Unnerstall U, Gaul U, Segal E (2007) The role of site accessibility in microRNA target recognition. Nat Genet 39:1278-1284. PMID: 17893677
24. Kruger J, Rehmsmeier M (2006) RNAhybrid: microRNA target prediction easy, fast and flexible. Nucleic Acids Res 34:W451-454. PMID: 16845047
25. Benjamini Y, Hochberg Y (1995) Controlling the False Discovery Rate-a Practical and Powerful Approach to Multiple Testing. Journal of the Royal Statistical Society Series B-Methodological 57:289-300.
26. Cai J, Wu J, Zhang H, Fang L, Huang Y, Yang Y, et al. (2013) miR-186downregulation correlates with poor survival in lung adenocarcinoma, where it interferes with cell-cycle regulation. Cancer Res 73:756-766. doi: 10.1158/0008-5472. CAN-12-2651 PMID: 23204228
27. Li H, Yin C, Zhang B, Sun Y, Shi L, Liu N, et al. (2013) PTTG1 promotes migration and invasion of human non-small cell lung cancer cells and is modulated by miR-186. Carcinogenesis 34:2145-2155. doi: 10.1093/carcin/bgt158 PMID: 23671127
28. Erdmann K, Kaulke K, Thomae C, Huebner D, Sergon M, Froehner M, et al. (2014) Elevated expression of prostate cancer-associated genes is linked to down-regulation of microRNAs. BMC Cancer 14:82. doi: 10.1186/1471-2407-14-82 PMID: 24517338
29. Kim SY, Lee YH, Bae YS (2012) MiR-186, miR-216b, miR-337-3p, and miR-760 cooperatively induce cellular senescence by targeting alpha subunit of protein kinase CKII in human colorectal cancer cells. Biochem Biophys ResCommun 429:173-179. doi: 10.1016/j.bbrc.2012.10.117 PMID: 23137536
30. Bossel Ben-Moshe N, Avraham R, Kedmi M, Zeisel A, Yitzhaky A, Yarden Y, et al. (2012) Contextspecific microRNA analysis: identification of functional microRNAs and their mRNA targets. Nucleic Acids Res 40:10614-10627. doi: 10.1093/nar/gks841 PMID: 22977182
31. Flandez M, Cendrowski J, Canamero M, Salas A, Del Pozo N, Schoonjans K, et al. (2014) Nr5a2 heterozygosity sensitises to, and cooperates with, inflammation in KRas (G12V)-driven pancreatic tumourigenesis. Gut 63:647-655. doi: 10.1136/gutjnl-2012-304381 PMID: 23598351
32. Von Figura G, Morris JPt, Wright CV, Hebrok M (2014) Nr5a2 maintains acinar cell differentiation and constrains oncogenic Kras-mediated pancreatic neoplastic initiation. Gut 63:656-664. doi: 10.1136/gutjnl-2012-304287 PMID: 23645620
33. Molero X, Vaquero EC, Flandez M, Gonzalez AM, Ortiz MA, Cibrian-Uhalte E, et al. (2012) Gene expression dynamics after murine pancreatitis unveils novel roles for Hnf1alpha in acinar cell homeostasis. Gut 61:1187-1196. doi: 10.1136/gutjnl-2011-300360 PMID: 21948943
34. Petersen GM, Amundadottir L, Fuchs CS, Kraft P, Stolzenberg-Solomon RZ, Jacobs KB, et al. (2010) A genome-wide association study identifies pancreatic cancer susceptibility loci on chromosomes 13q22.1, 1q32.1 and5p15.33. Nat Genet 42:224-228. doi: 10.1038/ng.522 PMID: 20101243
35. Kefas B, Comeau L, Floyd DH, Seleverstov O, Godlewski J, Schmittgen T, et al. (2009) The neuronal microRNA miR-326 acts in a feedback loop with notch and has therapeutic potential against brain tumors. J Neurosci 29:15161-15168. doi: 10.1523/JNEUROSCI.4966-09.2009 PMID: 19955368
36. Wang S, Lu S, Geng S, Ma S, Liang Z, Jiao B (2013) Expression and clinical significance of microRNA-326 in human glioma miR-326 expression in glioma. Med Oncol 30:373. doi: 10.1007/s 12032-012-0373-y PMID: 23292865
37. Kefas B, Comeau L, Erdle N, Montgomery E, Amos S, Purow B (2010) Pyruvate kinase M2 is a target of the tumor-suppressive microRNA-326 and regulates the survival of glioma cells. Neuro Oncol 12:1102-1112. doi: 10.1093/neuonc/noq080 PMID: 20667897